The Filing Desk

AtriCure vs TransMedics Group

AtriCure ATRC · TransMedics Group TMDX · Health Care Equipment

TransMedics Group reported revenue of $606 million in fiscal 2025, about the same as AtriCure's $534 million in fiscal 2025. AtriCure's revenue grew 14.9% in its latest year, and TransMedics Group's grew 37.1%. AtriCure had an operating margin of -1.8%, against 17.9% at TransMedics Group. Free cash flow was $48 million at AtriCure and $134 million at TransMedics Group.

Side by side

AtriCureTransMedics Group
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$534M$606M
Revenue growth14.9%37.1%
Revenue growth a year, last 5 years20.9%88.3%
Gross margin75.0%59.9%
Operating margin−1.8%17.9%
Net margin−2.1%31.4%
Free cash flow$48M$134M
Free cash flow margin9.0%22.1%
Return on capital−1.9%27.5%
Net debt to EBITDA−8.9x−0.2x
Dividends and buybacks$0M$0M
Change in diluted share count1.7%15.1%
Last close$56.84$91.38
P/E at the last close189.5×25.0×
Insider trades, last 12 monthssold $4.4 millionbought $1.1 million, sold $4.7 million
Piotroski F-score7 of 97 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AtriCureTransMedics Group
Operating margin
Percent of revenue
AtriCureTransMedics Group
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AtriCureTransMedics Group

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AtriCure and TransMedics Group pages.